These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease. Pai RL; Japp AS; Gonzalez M; Rasheed RF; Okumura M; Arenas D; Pierson SK; Powers V; Layman AAK; Kao C; Hakonarson H; van Rhee F; Betts MR; Kambayashi T; Fajgenbaum DC JCI Insight; 2020 May; 5(9):. PubMed ID: 32376796 [TBL] [Abstract][Full Text] [Related]
5. Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports. Ferrero S; Ragaini S J Med Case Rep; 2021 Mar; 15(1):105. PubMed ID: 33676575 [TBL] [Abstract][Full Text] [Related]
13. Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology. Soudet S; Fajgenbaum D; Delattre C; Forestier A; Hachulla E; Hatron PY; Launay D; Terriou L Curr Res Transl Med; 2018 Sep; 66(3):83-86. PubMed ID: 30108026 [TBL] [Abstract][Full Text] [Related]
14. Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway. Sumiyoshi R; Koga T; Fukui S; Furukawa K; Momoki M; Ichinose K; Yano S; Kawakami A Clin Immunol; 2023 Nov; 256():109798. PubMed ID: 37778714 [TBL] [Abstract][Full Text] [Related]
15. Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease. Pierson SK; Stonestrom AJ; Shilling D; Ruth J; Nabel CS; Singh A; Ren Y; Stone K; Li H; van Rhee F; Fajgenbaum DC Am J Hematol; 2018 Jul; 93(7):902-912. PubMed ID: 29675946 [TBL] [Abstract][Full Text] [Related]
16. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500 [TBL] [Abstract][Full Text] [Related]
17. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study. Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137 [TBL] [Abstract][Full Text] [Related]